Phase III Randomized Controlled Study Comparing Survival

Project: Research project

Project Details

Description

Phase III Randomized Controlled Study Comparing Survival of Patients w/Unresectable Hepatocellular Carcinoma (HCC) Treated w/Thymitaq to Patients Treated with Doxorubicin
StatusFinished
Effective start/end date8/24/01 → 8/23/09

Funding

  • EXIMIAS PHARM CORP